Transforming Alzheimer’s Disease Detection – Collaboration with Aptamer Group
The CSO at Aptamer group spoke recently in an interview with BioPharma APAC about Neuro-Bio's ongoing partnership in which to develop Optimer binders to enable a lateral flow test for the early detection of Alzheimer's disease. He also covered how a move away from...
THENA Capital podcast with Baroness Susan Greenfield
Baroness Susan Greenfield sharing her perspective with Esther Reynal de St Michel Richardot on these important topics: Healthcare-related challenges that policy making is trying to address How it is impacting how innovations can reach patients The importance of having...
Neuro-Bio and Aptamer enter the second phase of Alzheimer’s test development
At Neuro-Bio, we’re thrilled at entering this next phase of development with Aptamer Group: the first phase proved productive and very promising. Now, this next stage takes us closer to realising a highly novel and much needed technology for detecting...
Xenopat Meeting – Barcelona 15/02/2024
Our CEO Susan Greenfield and Operations Direction Sara Garcia-Rates, joined Xenopat for a face-to-face meeting in Barcelona where they shared the progress made for the Tecniospring Industry project “Development of a T14 Inhibitor for Treatment of ColoRectal Cancer”,...
Baroness Greenfield speaks at “Club Ultima Hora” Debate Forum in Palma de Mallorca
The event (8th February 2024) is part of Ultima Hora's conference series titled "Values" and is jointly organised with the University if the Balearic Islands. On this occasion, it is focused on exploring the future of technology, the internet, its utilization and its...
Baroness Greenfield speaks at the House of Lords debate 18/01/2024 – “Plans to create parity of health and social care to address dementia”.
To read more on the debate and what will be discussed, please click on the link below:
https://www.alzheimers.org.uk/sites/default/files/2024-01/240118%20Alzheimer%27s%20Society%20Briefing%20-%20Lords%20question%20for%20short%20debate%20on%20dementia_0.pdf
The Chief Scientific Officer and the Head of Finance discuss Neuro-Bio’s progress in financial matters
Sara Garcia Rates and Javier Audibert were pleased to discuss around the table the tactics involved in successful grant applications and how to best make use of experience. The methodology of preparing a pitch to convince investors that you have the outlay to provide...
One of the proud winners of the Rosalind Franklin research residencies
https://www.rfi.ac.uk/winners-of-50k-franklin-research-residencies-announced/
Susan Greenfield speaking at “The Business Case for Ageing Research” Workshop – 14th November 2023
The ‘Building Links in Ageing Science and Translation’ (BLAST) network aims to bring people together to form consortia to develop new knowledge and interventions to improve the health of older people. Sara Garcia Rates, COO stated “The BLAST workshop was an excellent...